Ï㽶ÊÓƵ

The Rosalind and Morris Goodman Cancer Institute (GCI) and Department of Biochemistry are mourning the loss of Philip E. Branton, PhD, a dear colleague, friend, and brilliant scientist whose career profoundly shaped cancer research. Formerly Chair of the Department of Biochemistry (1990–2000), and a Full Member of the McGill Cancer Centre (now the GCI) and the Gerald Bronfman Department of Oncology, Professor Branton made pioneering contributions to the fields of virology, cell death, and tumor suppression for more than five decades.

Professor Branton was a pioneer in the study of viral oncogenesis and was one of the first scientists to show that viruses can attack tumour suppressor pathways to cause cancer. His groundbreaking work on human adenoviruses, particularly the viral proteins E1A, E1B, E4orf4 and E4orf6, significantly advanced our understanding of how viruses manipulate cellular processes, shedding light on critical mechanisms of cancer development. His work has had far-reaching implications for cancer therapies and remain influential in the development of novel treatments.

Professor Branton’s impact extended beyond research. He played a pivotal role in shaping cancer research in Canada, serving as the inaugural Scientific Director of the Institute of Cancer Research at the Canadian Institutes of Health Research as well as spearheading the formation of the Canadian Cancer Research Alliance. He also co-founded GeminX Biotechnologies, a company focused on developing cancer treatments, which led to the clinical development of innovative anti-cancer drugs.

Throughout his career, Phil was honored with numerous prestigious awards, including the R.M. Taylor Medal from the Canadian Cancer Society, Ï㽶ÊÓƵ's Medal for Exceptional Academic Achievement, and the Queen Elizabeth II Diamond Jubilee Medal in 2013. He was appointed an Officer of the Order of Canada in 2014, recognizing his exceptional contributions to science and leadership. His fellowship with the Royal Society of Canada, awarded in 2002, further attests to his distinguished academic legacy.

As a respected mentor, Professor Branton supervised over 45 graduate students and postdoctoral fellows, many of whom are successful leaders and scientists such as Michel L. Tremblay and José Teodoro, helping to cultivate the next generation of researchers. He authored more than 120 peer-reviewed publications, making significant contributions to the fields of virology and oncology.

His extensive research has left a lasting legacy in the global fight against cancer, and his work continues to inspire advancements in cancer biology and therapeutic strategies. His profound contributions to both science and academia will be remembered and celebrated for many years to come. His larger than life personality and commitment to building and supporting Canadian Cancer Research will remain with us.

Our thoughts and condolences are with his family, his former colleagues and friends, and all who were touched by his remarkable life and work.

The Rosalind and Morris Goodman Cancer Institute and Department of Biochemistry will update the community with information on an upcoming memorial service.

Ìý

The Department of Biochemistry, Ï㽶ÊÓƵ
The Rosalind and Morris Goodman Cancer Institute